The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Measurable residual disease response in acute myeloid leukemia treated with venetoclax and azacitidine.
 
Keith Pratz
Consulting or Advisory Role - Abbvie; Astellas Pharma; Boston Biomedical
Research Funding - Abbvie; Agios; Daiichi Sankyo; Millenium Pharamceuticals
 
Brian Andrew Jonas
Consulting or Advisory Role - Abbvie; Genentech; GlycoMimetics; Jazz Pharmaceuticals; Takeda; Tolero Pharmaceuticals; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Accelerated Medical Diagnostics (Inst); Amgen (Inst); Arog (Inst); Celgene (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Hanmi (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); LP Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Sigma-Tau (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Vinod Pullarkat
Honoraria - Abbvie; Amgen; Genentech; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie; Amgen; Genentech; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
 
Christian Recher
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Janssen; Jazz Pharmaceuticals; MacroGenics; Novartis; Otsuka; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Amgen (Inst); Astellas Oncology (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); MaaT Pharma (Inst); Novartis (Inst); Roche (Inst)
 
Andre C. Schuh
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Agios; Amgen; Celgene; Pfizer
 
Michael J. Thirman
Consulting or Advisory Role - Abbvie; Janssen; Pharmacyclics
Research Funding - Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pharmacyclics (Inst); Syndax (Inst); TG Therapeutics (Inst); Tolero Pharmaceuticals (Inst)
 
Jacqueline Suen Garcia
Consulting or Advisory Role - Abbvie; Astellas Pharma; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Prelude Therapeutics (Inst)
 
Courtney Denton Dinardo
Leadership - Notable Labs
Stock and Other Ownership Interests - Notable Labs
Honoraria - Abbvie; Agios; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Takeda
Consulting or Advisory Role - Abbvie; Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Vladimir Vorobyev
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Roche; Sanofi; Takeda
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Agios (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Celgene (Inst); IQVIA (Inst); Janssen (Inst); Novartis (Inst); PAREXEL (Inst); Pfizer (Inst); PPD (Inst); Roche (Inst); Sanofi (Inst); Verastem (Inst)
 
Nicola Fracchiolla
Consulting or Advisory Role - Abbvie; Amgen; Daiichi Sankyo; Gilead Sciences; Novartis; Pfizer
 
Su-Peng Yeh
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Astex Pharmaceuticals; Janssen; Takeda
 
Jun Ho Jang
Speakers' Bureau - Novartis; Novartis
 
Muhit Ozcan
Honoraria - Takeda
Research Funding - Abbvie; Archigen Biotech; Bayer; Celgene; Janssen; Merck; Pharmacyclics; Roche; Takeda
Travel, Accommodations, Expenses - Abdi Ibrahim; Amgen; Bristol-Myers Squibb; Janssen; Roche; Sanofi; Takeda
 
Kazuhito Yamamoto
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Janssen; Kyowa Hakko Kirin; Meiji Seika Kaisha; Micron; MSD; Mundipharma; Nippon Shinyaku; Novartis; Ono Pharmaceutical; Otsuka; Sanofi; Sumitomo Dainippon; SymBio Pharmaceuticals; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo; Eisai; HUYA Bioscience International; Janssen; Kyowa Hakko Kirin; Meiji Seika Kaisha; Ono Pharmaceutical; Stemline Therapeutics; Takeda
Research Funding - Abbvie (Inst); ARIAD (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Chugai Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Incyte (Inst); MSD (Inst); Mundipharma (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Solasia Pharma (Inst); SymBio Pharmaceuticals (Inst); Takeda (Inst); Yakult Pharmaceutical (Inst); Zenyaku Kogyo (Inst)
 
Arpad Illes
Consulting or Advisory Role - Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Seagen; Takeda
Travel, Accommodations, Expenses - Janssen; Novartis; Pfizer; Roche
 
Ying Zhou
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Monique Dail
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Brenda Chyla
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jalaja Potluri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Hartmut Dohner
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Celgene; Helsinn Therapeutics; Janssen Oncology; Jazz Pharmaceuticals; Novartis; Roche
Research Funding - Amgen (Inst); Arog (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)